Osteoporosis in Orthopedics: Biomechanics, Fracture Patterns & Surgical Management
Key Takeaway
Osteoporosis significantly impacts orthopedic surgery by compromising bone strength, altering microarchitecture, and leading to complex fragility fractures. This necessitates specialized surgical approaches, considering reduced screw pull-out strength, increased comminution, and the need for robust fixation. Understanding bone biomechanics is crucial for effective preventive strategies and operative management of these challenging fractures.
An 82-year-old female presents following a fall from standing height with a displaced femoral neck fracture. You are planning the surgical management. How does the systemic nature of osteoporosis influence your choice of fixation versus arthroplasty, and what are the specific biomechanical considerations you must account for in this patient?
Candidate: In an elderly patient with a displaced femoral neck fracture, I would perform an arthroplasty, either a hemiarthroplasty or total hip replacement, rather than internal fixation. This is because osteoporotic bone has poor hold for screws, leading to high failure rates such as non-union or AVN. Biomechanically, I need to ensure early mobilization, as these patients have poor bone stock and are at high risk of medical complications like pneumonia or DVT if bedbound.
Candidates often focus solely on "poor bone stock" without defining the underlying pathophysiology (e.g., loss of connectivity, conversion of plate-like to rod-like trabeculae, or increased porosity). They may also fail to mention the 20-30% mortality risk or the necessity of immediate weight-bearing, which is the primary driver for choosing arthroplasty over ORIF in this demographic.
The candidate should structure their response: 1) Clinical Decision: Prioritize arthroplasty over ORIF due to the high rate of fixation failure (cut-out/non-union) in osteoporotic bone and the need for immediate, full weight-bearing. 2) Pathophysiology: Mention the reduced area moment of inertia, cortical thinning, and the shift from plate-like to rod-like trabecular structures, which drastically reduces screw pull-out strength. 3) Technical Caveat: If internal fixation were performed (e.g., in a younger patient), emphasize the Tip-Apex Distance (TAD) < 25mm as the critical surgeon-controlled variable for stability.
You are managing a 78-year-old patient with an unstable intertrochanteric fracture. You decide on a cephalomedullary nail. What technical parameters are most important to prevent construct failure in this osteoporotic patient, and what is the role of cement augmentation?
Candidate: I would ensure the lag screw is placed centrally in the femoral head and aim for a Tip-Apex Distance (TAD) of less than 25mm. I would also use a trochanteric entry nail to avoid iatrogenic fracture. Cement augmentation can be used via the screw to improve purchase if the bone is very poor.
Failing to mention the "why" behind the TAD or the specific risk of cut-out. Candidates often overlook the importance of the lateral entry point, which is crucial in osteoporotic patients to prevent secondary fractures of the greater trochanter.
The ideal answer addresses: 1) TAD: Emphasizing TAD < 25mm to minimize the risk of cut-out. 2) Entry Point: Use of a trochanteric entry nail to minimize stress in the fragile femoral neck. 3) Cement: Explaining that augmentation via fenestrated screws increases the bone-implant interface and improves shear strength in osteoporotic cancellous bone. 4) Biology: Briefly mentioning the need for "load-sharing" rather than "load-bearing" constructs and the importance of early mobilization.
A patient has successfully undergone fixation of an osteoporotic proximal humerus fracture. The surgeon is concerned about future fragility fractures. How would you approach secondary prevention in this patient?
Candidate: I would refer the patient to a Fracture Liaison Service. I would test their Vitamin D and Calcium levels and likely start them on a bisphosphonate or suggest an anabolic agent like teriparatide if the bone quality is very poor.
Treating it as a "surgical success" and forgetting that a fragility fracture is a sentinel event. Failing to differentiate between antiresorptive (bisphosphonates) and anabolic (teriparatide/romosozumab) therapies, and omitting the need for a formal metabolic workup.
A structured response: 1) Sentinel Event: Recognize the fracture as a marker for high future risk. 2) Systemic Workup: Order DEXA and labs (Vitamin D, PTH, Calcium, Thyroid) to rule out secondary osteoporosis. 3) Intervention: Use of bisphosphonates for antiresorptive care; reserve anabolic agents (Teriparatide/Romosozumab) for severe cases. 4) Programmatic Approach: Mentioning the "Own the Bone" or FLS model to ensure long-term adherence and monitoring.
